Find the Perfect Plan for Your Investment Journey
R
Latest price
52 Week Range
CA$0.13 - CA$0.33
Next Earnings Date
Jun 30 2025 (Estimate)
Next Earnings Date
Jun 30 2025 (Est.)
Latest price
Market Cap | CA$23.76M |
EV | CA$26.33M |
Shares Outstanding | 130.16M |
Beta | -0.03 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 10.60% |
EPS | -20.90% |
Operating Cash Flow | -12.20% |
Free Cash Flow | -12.80% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
R
Rapid Dose Therapeutics Corp.
DOSE
Sector
Healthcare
Industry
Biotechnology
CEO
Upsdell, Mark
Employees
Website
rapid-dose.comIPO Date
2010-02-10
Headquarters
1121 Walker's Line, Unit 3A, Burlington, Ontario, L7N 2G4, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved